2025
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR.
Neoplasia (New York, N.Y.)
•Cancer Specialist (Oncologist), Surgical Oncologist (Surgical Specialist - Cancer)
Dr. Hughes' research interests center on improving the understanding of gastrointestinal tumor biology through genetic analysis and assessing the response of these historically stubborn tumors to a new class of medications called tyrosine kinase inhibitors.
173 publications
2025
Neoplasia (New York, N.Y.)
•2025
Pancreas
•2025
The Journal of surgical research
•2025
Pancreas
•2024
Journal of robotic surgery
•